Bruce Petersen

1.8k total citations · 1 hit paper
26 papers, 966 citations indexed

About

Bruce Petersen is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Bruce Petersen has authored 26 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Genetics and 6 papers in Oncology. Recurrent topics in Bruce Petersen's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (5 papers). Bruce Petersen is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (5 papers). Bruce Petersen collaborates with scholars based in United States, Norway and India. Bruce Petersen's co-authors include Jiapeng Wang, Mingjiang Xu, Zhe Li, Chen‐Leng Cai, Xiaoqiang Cai, Feng‐Chun Yang, Vesna Najfeld, John Mascarenhas, Min Lü and Ronald Hoffman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The American Journal of Surgical Pathology.

In The Last Decade

Bruce Petersen

26 papers receiving 958 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

2011 507 citations Zhe Li, Xiaoqiang Cai et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Petersen United States	13	580	506	370	96	91	26	966
Hirotoshi Sakaguchi Japan	13	312 0.5×	442 0.9×	204 0.6×	108 1.1×	32 0.4×	51	752
Daichi Inoue Japan	16	473 0.8×	482 1.0×	212 0.6×	115 1.2×	50 0.5×	55	864
Marianne Rissler Sweden	15	322 0.6×	565 1.1×	187 0.5×	219 2.3×	84 0.9×	32	1.0k
Yukiko Komeno Japan	20	549 0.9×	445 0.9×	131 0.4×	189 2.0×	29 0.3×	44	984
Salman Fazal United States	12	192 0.3×	394 0.8×	320 0.9×	113 1.2×	121 1.3×	51	653
OA Haas Austria	15	407 0.7×	656 1.3×	221 0.6×	52 0.5×	57 0.6×	18	904
Thomas Stübig Germany	15	268 0.5×	573 1.1×	242 0.7×	177 1.8×	112 1.2×	25	792
W.‐K. Hofmann Germany	15	248 0.4×	194 0.4×	203 0.5×	304 3.2×	162 1.8×	22	905
Simon V. van Reijmersdal Netherlands	11	363 0.6×	323 0.6×	83 0.2×	99 1.0×	47 0.5×	25	1.1k
Mineo Kurokawa Japan	10	304 0.5×	387 0.8×	177 0.5×	131 1.4×	13 0.1×	24	728

Countries citing papers authored by Bruce Petersen

Since Specialization

Citations

This map shows the geographic impact of Bruce Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Petersen more than expected).

Fields of papers citing papers by Bruce Petersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Petersen. The network helps show where Bruce Petersen may publish in the future.

Co-authorship network of co-authors of Bruce Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Petersen. A scholar is included among the top collaborators of Bruce Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Petersen. Bruce Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaoli, Raajit K. Rampal, Joseph Tripodi, et al.. (2022). Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase. JCI Insight. 7(8). 3 indexed citations

Bhardwaj, Swati, Shafinaz Hussein, Siraj M. El Jamal, et al.. (2021). Digital AI in Hematology - Integration of the Scopio Labs x100 Scanner with Newly Implemented AI Capabilities into Routine Clinical Workflow. Blood. 138(Supplement 1). 4932–4932. 2 indexed citations

Ghosh, Sharmila, Jacques Azzi, Kambiz Nael, et al.. (2021). Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report. Acta Haematologica. 145(1). 97–105. 1 indexed citations

Satturwar, Swati, Mary Fowkes, Carol Farver, et al.. (2021). Postmortem Findings Associated With SARS-CoV-2. The American Journal of Surgical Pathology. 45(5). 587–603. 69 indexed citations

Fernandez‐Pol, Sebastian, Bruce Petersen, Jo-Ellen Murphy, et al.. (2020). Two Cases With Features of Lymphocyte Variant Hypereosinophilic Syndrome With STAT3 SH2 Domain Mutations. The American Journal of Surgical Pathology. 45(2). 193–199. 7 indexed citations

Mascarenhas, John, Bridget K. Marcellino, Min Lü, et al.. (2019). A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). Leukemia Research. 88. 106272–106272. 22 indexed citations

Hao, Yansheng, Jane Houldsworth, Bart Barlogie, et al.. (2019). Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma. Modern Pathology. 33(2). 188–195. 2 indexed citations

Mascarenhas, John, Lonette Sandy, Min Lü, et al.. (2016). A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). Leukemia Research. 53. 13–19. 38 indexed citations

Keyzner, Alla, Erin Moshier, Bruce Petersen, et al.. (2016). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis. Biology of Blood and Marrow Transplantation. 22(12). 2180–2186. 14 indexed citations

10.

Petersen, Bruce, et al.. (2015). Donor Cell Myeloid Sarcoma in an Umbilical Cord Transplant Patient: A Case Report and a Review of the Literature. SHILAP Revista de lepidopterología. 2015. 1–4. 6 indexed citations

11.

Chary, Michael, et al.. (2015). Paraneoplastic orthostatic hypotension associated with acute myeloid leukemia.. PubMed. 19(15). 2934–7. 2 indexed citations

12.

Rasouli, Jonathan J., Shyam A. Patel, Branko Skovrlj, et al.. (2013). Primary extranodal marginal zone lymphoma involving the skull. Journal of Clinical Neuroscience. 21(2). 351–353. 2 indexed citations

13.

Mascarenhas, John, Min Lü, Timmy Li, et al.. (2013). A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post‐polycythaemia vera/essential thrombocythaemia myelofibrosis (post‐PV/ET MF). British Journal of Haematology. 161(1). 68–75. 66 indexed citations

14.

Arita, Adriana, Daniel C. McFarland, June H. Myklebust, et al.. (2013). Signaling Pathways in Lymphoma: Pathogenesis and Therapeutic Targets. Future Oncology. 9(10). 1549–1571. 14 indexed citations

15.

Najfeld, Vesna, et al.. (2012). An unusual case of donor‐derived myelodysplastic syndrome following double‐unit umbilical cord blood transplantation in acute lymphoblastic leukemia. American Journal of Hematology. 87(9). 931–933. 3 indexed citations

16.

Mascarenhas, John, Mark Heaney, Vesna Najfeld, et al.. (2012). Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium. Leukemia Research. 36(12). 1500–1504. 37 indexed citations

17.

Najfeld, Vesna, et al.. (2012). A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature. Clinical Lymphoma Myeloma & Leukemia. 13(2). 175–179. 15 indexed citations

18.

Li, Zhe, Xiaoqiang Cai, Chen‐Leng Cai, et al.. (2011). Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. 118(17). 4509–4518. 507 indexed citations breakdown →

19.

Mascarenhas, John, Á Rodríguez, Min Lü, et al.. (2011). Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis. Blood. 118(21). 794–794. 9 indexed citations

20.

Petersen, Bruce, Stephen G. Jenkins, Songyang Yuan, Carin Lamm, & Arnold H. Szporn. (2007). NOCARDIA FARCINICA ISOLATED FROM BRONCHOALVEOLAR LAVAGE FLUID OF A CHILD WITH CYSTIC FIBROSIS. The Pediatric Infectious Disease Journal. 26(9). 858–859. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact